Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice

Nature Medicine

Volumn 5, Issue 10, 1999, Pages 1199-1202

  Fabre, Jean Etienne ^a   Nguyen, Mytrang ^a   Latour, Anne ^a   Keifer, Jayne A ^a   Audoly, Laurent P ^b   Coffman, Thomas M ^b   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM; CYCLIC AMP; PURINE P2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HEMOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE; THROMBOEMBOLISM; THROMBOGENESIS;

ADENOSINE DIPHOSPHATE; ANIMALS; BLEEDING TIME; BLOOD PLATELETS; CELL SIZE; CYCLIC AMP; IMMUNITY, NATURAL; MICE; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; MUTAGENESIS; PLATELET AGGREGATION; RECEPTORS, PURINERGIC P2; THROMBOEMBOLISM;

EID: 0032826036     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/13522     Document Type: Article

References (25)

1. Siess, W. Molecular mechanisms of platelet activation. Physiol.Rev. 69, 58-178 (1989).
2. Packham, M.A. Role of platelets in thrombosis and hemostasis. Can. J. Physiol. Pharmacol. 72, 278-284 (1994).
3. Maffrand, J.P., Bernat, A., Delebassée, D., Defreyn, G., Cazenave, J.P. & Gordon, J.L. ADP plays a key role in thrombogenesis in rats. Thromb. Haemost. 59, 225-230 (1988).
4. Fredholm, B. et al. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-156 (1994).
5. Heermskerk, J.W.M. & Sage, S.O. Calcium signalling in platelets and other cells. Platelets 5, 295-316 (1994).
6. 1 receptor to phospholipase C. Br. J. Pharmacol. 122, 1021-1024 (1997).
7. Macfarlane, D.E. in Responses and Metabolism (ed. Holmsen, H), 19-36 (CRC, Boca Raton, Florida, 1987).
8. Bearer, E.L. Cytoskeletal domains in the activated platelet. Cell Motil. Cytoskel. 30, 50-66 (1995).
9. Munro, J.M. & Cotran, R.S. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58, 249-261 (1988).
10. AntiplateletTrialists. Collaborative overview of randomised trials of antiplatelet therapy-ll: maintenance of vascular graft or arterial patency by antiplatelet therapy. Br. Med. J. 308, 159-168 (1994).
11. Fingerle, J., Johnson, R., Clowes, A.W., Majesky, M.W. & Reidy, M.A. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc. Natl. Acad. Sci. USA 86, 8412-8416 (1989).
12. DiMinno, G. & Silver, M.J. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharmacol. Exp. Ther. 225, 57-60 (1983).
13. Daniel, J.L. et al. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct receptors on human platelets. J. Biol. Chem. 273, 2024-2029 (1998).
14. Geiger, J., Hönig-Liedi, P., Schanzenbächer, P. & Walter, U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur. J. Pharmacol. 251, 235-245 (1998).
15. Savi, P. et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett. 422, 291-295 (1998).
16. ADP-receptors. Br. J. Pharmacol. 124, 157-164 (1998).
17. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br. J. Haemotol. 103, 858-866 (1998).
18. Vial, C., Hechler, B., Leon, C., Cazenave, J.P. & Gachet, C. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb. Haemost. 78, 1500-1504 (1997).
19. MacKenzie, A.B., Mahaut-Smith, M.P. & Sage, S.O. Activation of receptor operated channels via P2X, not P2T purinoceptors in human platelets. J. Biol. Chem. 271, 2879-2881 (1996).
20. Leon, C. et al. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastics cells. FEBS Lett. 403, 26-30 (1997).
21. Janssens, R. et al. Cloning and tissue distribution of the human P2Y1 receptor. Biochem. Biophy. Res. Comm. 221, 588-593 (1996).
22. Leon, C., Vial, C., Cazenave, J.P. & Gachet, C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 171, 295-297 (1996).
23. Jin, J., Daniel, J.L. & Kunapuli, S. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem. 273, 2030-2034 (1998).
24. q,-deficient mice. Nature 389, 183-186 (1997).
25. Hechler, B. et al. The P2Y1 receptor is necessary for adenosine 5′ -diphosphate-induced platelet aggregation. Blood 92, 152-159 (1998).